Article
Molecular remission at the end of treatment is a necessary goal for a good outcome in ELN favorable-risk acute myeloid leukemia: a real-life analysis on 201 patients by the Rete Ematologica Lombarda network.
Annals of hematology - 1 Nov 2018
Zappasodi Patrizia, Marbello Laura, Borlenghi Erika, Fumagalli Monica, Bernardi Massimo, Fracchiolla Nicola, Mancini Valentina, Da Vià Matteo, Ravano Emanuele, Cerqui Elisa, Ferretti Virginia Valeria, Rocca Barbara, Calvello Celeste, Cazzola Mario, Castagnola Carlo, Rossi Giuseppe
Abstract excerpt
Favorable acute myeloid leukemia (AML) patients (pts.) demonstrate a relatively good outcome with standard induction; thus, pts. are generally not addressed to allogeneic transplant in first remission. However, it is not clear if also in a real-life setting, the outcome is homogeneous in the different favorable molecular groups and which are the parameters significantly associated to an increased relapse risk,...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.